2025
SJR Q1
JCR Q3 · 2,6
OA
25 matched articles
SCIE
Journal detail
Pharmacology Research and Perspectives
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
20521707
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,742
- Quartile Q1
- H-Index 53
- Cites/doc 2,48
- Docs (3y) 370
- Cites (3y) 984
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,6
- 5Y JIF 3,1
- JCI 0,61
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Neurology Q2
- Pharmacology, Toxicology and Pharmaceutics (miscellaneous) Q1
Areas
- Neuroscience
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q3 | 0,742 | 2,6 | 3,1 | 0,61 | Q3 | 53 |
| 2024 | Q1 | Q3 | 0,799 | 2,3 | 2,8 | 0,71 | Q2 | 47 |
| 2023 | Q1 | Q2 | 0,79 | 2,9 | 2,9 | 0,73 | Q2 | 47 |
| 2022 | Q1 | Q3 | 0,693 | 2,6 | 2,8 | 0,7 | Q2 | 47 |
| 2021 | Q1 | Q3 | 0,851 | 3 | 3,1 | 0,72 | Q2 | 47 |
| 2020 | Q1 | Q3 | 0,975 | 2,8 | 3,5 | 0,75 | Q2 | 47 |
| 2019 | Q1 | Q3 | 0,953 | 2,1 | — | 0,72 | Q2 | 47 |
| 2017 | Q1 | — | 1,005 | — | — | — | — | 47 |
| 2016 | Q1 | — | 0,896 | — | — | — | — | 47 |
| 2015 | Q1 | — | 0,508 | — | — | — | — | 47 |
| 2014 | Q2 | — | 0,262 | — | — | — | — | 47 |
| 2013 | — | — | — | — | — | — | — | 47 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 195/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 202/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 147/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 183/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 181/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 175/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 192/271 |